JP6712715B2 - 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 - Google Patents

結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 Download PDF

Info

Publication number
JP6712715B2
JP6712715B2 JP2016505515A JP2016505515A JP6712715B2 JP 6712715 B2 JP6712715 B2 JP 6712715B2 JP 2016505515 A JP2016505515 A JP 2016505515A JP 2016505515 A JP2016505515 A JP 2016505515A JP 6712715 B2 JP6712715 B2 JP 6712715B2
Authority
JP
Japan
Prior art keywords
composition
corn fiber
linear
soluble corn
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016505515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515388A (ja
JP2016515388A5 (OSRAM
Inventor
マリー ウィーヴァー コニー
マリー ウィーヴァー コニー
エイチ. ナカツ シンディ
エイチ. ナカツ シンディ
ウィリアムソン パトリシア
ウィリアムソン パトリシア
ジョゼフ ホフマン アンドルー
ジョゼフ ホフマン アンドルー
マール サンダーズ リサ
マール サンダーズ リサ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Primary Products Ingredients Americas LLC
Original Assignee
Purdue Research Foundation
Tate and Lyle Ingredients Americas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49081352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6712715(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Purdue Research Foundation, Tate and Lyle Ingredients Americas LLC filed Critical Purdue Research Foundation
Publication of JP2016515388A publication Critical patent/JP2016515388A/ja
Publication of JP2016515388A5 publication Critical patent/JP2016515388A5/ja
Application granted granted Critical
Publication of JP6712715B2 publication Critical patent/JP6712715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2016505515A 2013-03-22 2014-03-22 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 Active JP6712715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361804584P 2013-03-22 2013-03-22
US61/804,584 2013-03-22
PCT/US2014/031526 WO2014153554A1 (en) 2013-03-22 2014-03-22 Uses of soluble corn fiber for increasing colonic bacteria populations and increasing mineral absorption

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020074299A Division JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Publications (3)

Publication Number Publication Date
JP2016515388A JP2016515388A (ja) 2016-05-30
JP2016515388A5 JP2016515388A5 (OSRAM) 2017-04-27
JP6712715B2 true JP6712715B2 (ja) 2020-06-24

Family

ID=49081352

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016505515A Active JP6712715B2 (ja) 2013-03-22 2014-03-22 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途
JP2020074299A Active JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020074299A Active JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Country Status (8)

Country Link
US (2) US11129403B2 (OSRAM)
EP (2) EP2981180B2 (OSRAM)
JP (2) JP6712715B2 (OSRAM)
KR (1) KR102362975B1 (OSRAM)
CN (2) CN114468303A (OSRAM)
ES (1) ES2909102T3 (OSRAM)
GB (1) GB201312713D0 (OSRAM)
WO (1) WO2014153554A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013139861A1 (en) 2012-03-20 2013-09-26 Luc Montagnier Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
WO2019055717A1 (en) * 2017-09-13 2019-03-21 Evolve Biosystems, Inc. OLIGOSACCHARIDE COMPOSITIONS AND THEIR USE DURING THE TRANSIENT PHASES OF INTESTINAL MICROBIOMA OF A MAMMALIAN
BR112020010843A2 (pt) * 2017-11-30 2020-11-10 Glycom A/S oligossacarídeos do leite humano e composições sintéticas desses para modulação da microbiota
EP4044826A1 (en) * 2019-10-14 2022-08-24 Tate & Lyle Solutions USA LLC Flavor altering and/or sweetness enhancing compositions and methods and food and beverage products based thereon
CA3219750A1 (en) * 2021-06-22 2022-12-29 Muhammed Majeed Calebin-a for thermogenesis and dysbiosis
EP4494695A1 (en) 2022-03-18 2025-01-22 Meiji Co., Ltd Composition for controlling proliferation of bacterium in intestine, and use thereof
WO2023214185A1 (en) 2022-05-06 2023-11-09 Tate & Lyle Solutions Usa Llc Low sugar, high fiber chewable sweets
CN120699879A (zh) * 2025-09-01 2025-09-26 美益添生物医药(武汉)有限公司 副普雷沃氏菌的增菌剂、增菌培养基及应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS61219392A (ja) 1985-03-25 1986-09-29 Showa Sangyo Kk 高温度縮合反応による分岐オリゴ糖シラツプの製造方法
JPS63109791A (ja) 1986-10-27 1988-05-14 Showa Sangyo Co Ltd 分岐オリゴ糖シラツプの連続的製法
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
JPH03175989A (ja) 1989-12-01 1991-07-31 Chiyoda Corp 分岐オリゴ糖シラップ及びその製造方法
US6023797A (en) * 1997-04-01 2000-02-15 Brumfield; John David Comfort beach towel with inflatable pillow
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20030077255A1 (en) 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
KR100875576B1 (ko) 2001-04-27 2008-12-23 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 이소말토오스의 제조방법 및 용도
DE60231322D1 (de) 2001-11-12 2009-04-09 Mars Inc Nahrungsmittel für katzen und hunde
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
JP2007518394A (ja) 2003-08-14 2007-07-12 ザ バイオ バランス コーポレイション 細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
US7759105B2 (en) 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050095350A1 (en) 2003-09-22 2005-05-05 Grain Processing Corporation Nutritive food source including controlled energy release carbohydrate
GB0414655D0 (en) 2004-06-30 2004-08-04 Leuven K U Res & Dev Prebiotic
US20060210696A1 (en) 2005-03-17 2006-09-21 Chi-Li Liu Slowly digestible carbohydrate
MY144556A (en) 2005-10-24 2011-09-30 Nestec Sa Dietary fiber formulation and method of administration
CN101291597A (zh) * 2005-10-24 2008-10-22 雀巢技术公司 膳食纤维制剂和施用方法
US7608436B2 (en) 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
FR2897869B1 (fr) 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
CN101095698B (zh) 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
BRPI0810953A2 (pt) 2007-05-23 2014-10-14 Tate & Lyle Ingredientes Americas Inc Composição comestível, produto alimentício, método para diminuir a respota glicêmica de um mamífero a um produto alimentício, composição adoçante embalada para porção única, composição de xarope de milho, composição adoçante, suplemento de cálcio comestível, bebida dietética e progresso para preparar uma composição comestível.
CN101492997A (zh) * 2008-01-21 2009-07-29 姚小林 液压潜孔凿岩冲击器
WO2010015580A1 (en) 2008-08-04 2010-02-11 Dsm Ip Assets B.V. Production of beadlets comprising probiotic compounds
CN101744239A (zh) 2008-12-01 2010-06-23 青岛东海药业有限公司 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用
GB0903016D0 (en) 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
CN101537020B (zh) 2009-04-24 2012-05-02 东北制药集团公司沈阳第一制药厂 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂
EP2456891A4 (en) 2009-07-24 2013-04-03 Southwest Regional Pcr Llc DIAGNOSIS, DETECTION, QUANTIFICATION UNIVERSAL MICROBIENS, AND TARGETED THERAPY ON A SAMPLE
WO2011043654A1 (en) 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
BR112012011294B1 (pt) * 2009-11-12 2018-03-20 Nestec S.A. Composição nutricional para administração a um indivíduo
AU2011223002B2 (en) 2010-03-01 2015-07-02 Institut National De La Recherche Agronomique Method of diagnostic of obesity
US9386793B2 (en) 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
CN107251988A (zh) * 2010-08-25 2017-10-17 泰特&莱尔组分美国公司 合生素产品
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EP2670770A2 (en) 2011-02-03 2013-12-11 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. High molecular ordered fibrilar structures, method for their preparation and uses thereof
BR112014010660A2 (pt) * 2011-11-04 2017-05-09 Gen Mills Inc métodos e composições para modular bactéria gastrointestinal
EP3686284A1 (en) * 2012-05-18 2020-07-29 Genome Research Limited Methods and groups
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption

Also Published As

Publication number Publication date
EP2981180A1 (en) 2016-02-10
JP7055162B2 (ja) 2022-04-15
WO2014153554A1 (en) 2014-09-25
US20160058056A1 (en) 2016-03-03
KR20150135417A (ko) 2015-12-02
GB201312713D0 (en) 2013-08-28
US20220225654A1 (en) 2022-07-21
EP2981180B1 (en) 2021-12-29
CN114468303A (zh) 2022-05-13
CN105473004A (zh) 2016-04-06
JP2016515388A (ja) 2016-05-30
ES2909102T3 (es) 2022-05-05
KR102362975B1 (ko) 2022-02-15
EP2981180B2 (en) 2025-08-13
US11129403B2 (en) 2021-09-28
JP2020120675A (ja) 2020-08-13
EP4035734A1 (en) 2022-08-03

Similar Documents

Publication Publication Date Title
JP7055162B2 (ja) 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途
Megur et al. Prebiotics as a tool for the prevention and treatment of obesity and diabetes: classification and ability to modulate the gut microbiota
WO2017103019A1 (en) Mixture of hmos
JP2008504038A (ja) 前生物学的調製物
CN108778292A (zh) 包含肠膜明串珠菌产生的外泌多糖作为活性成分的用于预防或治疗代谢障碍的组合物
US20250197436A1 (en) Galactooligosaccharide composition
Van Loo Inulin-type fructans as prebiotics
Uyeno et al. Changes in mouse gastrointestinal microbial ecology with ingestion of kale
US20230034247A1 (en) Method and composition for treating or decreasing gut microbiome dysbiosis induced by a prior antibiotic treatment
US20250312388A1 (en) Bifidobacterium infantis formulations
JP2024501148A (ja) F.プラウスニッツイ(F.prausnitzii)の存在量を促進することにおいて使用するための2’-フコシルラクトース
Rastall Galacto‐oligosaccharides as prebiotic food ingredients
JP2024088889A (ja) 腸内細菌叢におけるRomboutsia属菌低減用組成物
CN116615117A (zh) 用于刺激普氏栖粪杆菌丰度的2’-岩藻糖基乳糖
HK40099493A (en) Oligosaccharide composition
Del Pozo de La Calle et al. Potential Effects of Sucralose and Saccharin on Gut Microbiota: A Review
Nettleton Dietary Modulators of Gut Microbiota: Impact on Metabolic Health and Behaviour
JP2024152695A (ja) ビフィズス菌の増殖用組成物および増殖方法ならびに乳酸および/またはピルビン酸の増加用組成物および増加方法
Saville et al. Oligosaccharides Derived from Xylan, Arabinan, and Mannan
CN121013657A (zh) 用于在个体中使用以支持脑发育和/或认知发育的包含人乳低聚糖的组合物
JP2023167322A (ja) 抗ストレス剤及びリラックス剤
EP3431093A1 (en) Wheat-derived polysaccharides for reduction of antibiotic resistance
WO2025247520A1 (en) Synthetic carbohydrate composition
JP2025535109A (ja) アンモニアのレベルの低減における使用のためのオリゴ糖組成物
Lee et al. Lactose: Uses in Industry and Biomedical Importance Lactose a Functional Disaccharide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160229

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170322

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170322

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180604

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190325

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200319

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20200414

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200417

R150 Certificate of patent or registration of utility model

Ref document number: 6712715

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250